Lipid Metabolism — MCQs

Q: Which organ does not utilise ketone bodies?

Liver. **Explanation** The correct answer is **A. Liver**. **1. Why the Liver cannot utilize Ketone Bodies:** The liver is the primary site for **ketogenesis** (the synthesis of ketone bodies), but it cannot utilize them for energy. This is because the liver lacks the essential enzyme **Thiophorase** (also known as Succinyl-CoA:3-ketoacid CoA transferase). In extrahepatic tissues, Thiophorase converts Acetoacetate into Acetoacetyl-CoA by transferring a CoA group from Succinyl-CoA. Without this enzyme, the liver cannot activate ketone bodies to enter the TCA cycle, preventing a "futile cycle" where the liver would consume the fuel it is supposed to export to the rest of the body. **2. Why the other options are incorrect:** * **B. Brain:** During prolonged fasting or starvation, the brain adapts to use ketone bodies (specifically 3-hydroxybutyrate and acetoacetate) as its primary energy source, reducing its dependence on glucose. * **C & D. Skeletal and Cardiac Muscles:** These tissues possess high levels of Thiophorase. In the early stages of fasting, muscles are the primary consumers of ketone bodies to spare glucose for the brain. **High-Yield NEET-PG Pearls:** * **Rate-limiting enzyme of Ketogenesis:** HMG-CoA Synthase (Mitochondrial). * **Ketone bodies include:** Acetone (non-metabolizable, excreted in breath), Acetoacetate, and β-Hydroxybutyrate. * **Site of Ketogenesis:** Mitochondria of hepatocytes. * **Key Enzyme for Utilization:** Thiophorase (absent in Liver). * **Clinical Sign:** "Fruity odor" of breath in Diabetic Ketoacidosis (DKA) is due to the excretion of Acetone.

Q: Reverse cholesterol transport is mediated by which lipoprotein?

HDL. **Explanation:** **Reverse Cholesterol Transport (RCT)** is the physiological process by which excess cholesterol is removed from peripheral tissues (like macrophages in the arterial wall) and transported back to the liver for excretion in bile. **HDL (High-Density Lipoprotein)** is the primary mediator of this process, which is why it is clinically referred to as "Good Cholesterol." The process involves: 1. **Efflux:** Free cholesterol is moved from cells to nascent HDL via **ABCA1 transporters**. 2. **Esterification:** The enzyme **LCAT** (Lecithin-Cholesterol Acyltransferase) converts free cholesterol into cholesterol esters, trapping them in the HDL core. 3. **Hepatic Uptake:** HDL delivers these esters to the liver via **SR-BI receptors** or transfers them to other lipoproteins via **CETP**. **Why other options are incorrect:** * **VLDL (Very Low-Density Lipoprotein):** Synthesized in the liver to transport endogenous triglycerides to peripheral tissues. * **LDL (Low-Density Lipoprotein):** Known as "Bad Cholesterol," it transports cholesterol **from** the liver **to** peripheral tissues. High levels are associated with atherosclerosis. * **IDL (Intermediate-Density Lipoprotein):** A transient product formed during the conversion of VLDL to LDL; it is not involved in RCT. **High-Yield NEET-PG Pearls:** * **Apo A-I:** The major apoprotein associated with HDL and a potent activator of LCAT. * **Tangier Disease:** A genetic deficiency of ABCA1 transporters resulting in extremely low HDL levels and orange-colored tonsils. * **Anti-atherogenic property:** HDL prevents foam cell formation, reducing the risk of Coronary Artery Disease (CAD).

Q: Lipid is required in the average diet because it:

provides essential fatty acids. **Explanation:** The primary nutritional requirement for lipids in the diet is to provide **Essential Fatty Acids (EFAs)**—specifically **Linoleic acid (omega-6)** and **Alpha-linolenic acid (omega-3)**. These are termed "essential" because the human body lacks the enzymes (**desaturases** beyond carbon 9) required to synthesize them de novo. These fatty acids are vital precursors for the synthesis of eicosanoids (prostaglandins, leukotrienes) and are structural components of cell membranes. **Analysis of Options:** * **Option A (High caloric value):** While lipids are the most energy-dense macronutrient (9 kcal/g), this is a characteristic, not the primary biological *requirement*. The body can derive sufficient calories from carbohydrates and proteins if necessary. * **Option C & D (Carbohydrate metabolism):** Lipids do not aid in the absorption of carbohydrates, nor are they necessary for their storage. Carbohydrates are stored as glycogen in the liver and muscles. **High-Yield NEET-PG Pearls:** 1. **EFA Deficiency:** Clinically presents as **Phrynoderma** (follicular hyperkeratosis/toad skin), poor wound healing, and alopecia. 2. **Fat-Soluble Vitamins:** Dietary lipids are also essential for the absorption of Vitamins **A, D, E, and K**. 3. **Arachidonic Acid:** It is considered "semi-essential" because it can be synthesized from Linoleic acid. 4. **Energy Storage:** Lipids are stored in the body as **Triacylglycerols (TAGs)** in adipose tissue, which serves as the body's main energy reservoir.

Q: What is the concentration of the reagent used for determining the Reichert-Meissl number?

0.1 N KOH. **Explanation:** The **Reichert-Meissl (RM) number** is a critical analytical constant used in lipid biochemistry to determine the amount of volatile, water-soluble fatty acids (primarily butyric and caproic acid) present in a fat or oil. **Why 0.1 N KOH is correct:** The RM number is defined as the number of milliliters of **0.1 N Potassium Hydroxide (KOH)** required to neutralize the steam-volatile, water-soluble fatty acids distilled from 5 grams of fat. KOH is the standard alkali used in this titration process because it effectively neutralizes the short-chain fatty acids (like butyric acid) that are characteristic of milk fats. **Analysis of Incorrect Options:** * **0.5 N KOH (B):** This concentration is too high. 0.5 N KOH is typically used in the determination of the **Saponification Number**, where a stronger alkali is needed to hydrolyze all fatty acids in a sample. * **0.1 N and 0.5 N NaOH (C & D):** While Sodium Hydroxide (NaOH) is a strong base, the standard protocol for RM number specifically mandates KOH. In lipid chemistry, KOH is preferred for many titrations because it is more soluble in organic solvents (like ethanol) often used during the preparation of fat samples. **High-Yield Clinical Pearls for NEET-PG:** * **Significance:** The RM number is primarily used to detect the **adulteration of Ghee or Butter**. * **Normal Value:** Pure Ghee/Butter has a high RM number (typically **24–30**) due to its high content of butyric acid. * **Adulteration:** If butter is adulterated with animal fats or vegetable oils (which have very low RM numbers, usually <1), the RM value of the sample will significantly decrease. * **Related Constant:** The **Polenske Number** also uses 0.1 N KOH but measures steam-volatile, water-**insoluble** fatty acids (like caprylic and capric acid).

Q: Which lipoprotein has the highest quantity of lipid and the lowest concentration of protein?

Chylomicrons. ### Explanation Lipoproteins are classified based on their **density**, which is determined by the ratio of lipids to proteins. Since lipids have a lower density than water and proteins have a higher density, the lipoprotein with the most lipid and least protein will be the least dense. **1. Why Chylomicrons are correct:** Chylomicrons are the largest and least dense of all lipoproteins. They consist of approximately **98-99% lipid** (predominantly exogenous triglycerides) and only **1-2% protein**. Because they have the highest lipid-to-protein ratio, they float to the top when plasma is left standing, forming a creamy supernate. **2. Analysis of Incorrect Options:** * **VLDL (Very Low Density Lipoproteins):** These are the second least dense. They contain about 90% lipid (mainly endogenous triglycerides) and 10% protein. * **LDL (Low Density Lipoproteins):** Known as "bad cholesterol," they contain about 75-80% lipid (primarily cholesterol) and 20-25% protein. * **HDL (High Density Lipoproteins):** Known as "good cholesterol," these are the smallest and densest. They have the **highest concentration of protein** (approx. 40-55%) and the lowest quantity of lipid. **3. High-Yield NEET-PG Pearls:** * **Electrophoretic Mobility:** On electrophoresis (pH 8.6), the order of mobility from origin to anode is: **Chylomicrons (Origin) < LDL (Beta) < VLDL (Pre-beta) < HDL (Alpha).** Note that VLDL moves faster than LDL despite being less dense. * **Apolipoprotein Markers:** * Chylomicrons: **Apo B-48** (unique marker). * VLDL/IDL/LDL: **Apo B-100**. * HDL: **Apo A-I** (activates LCAT). * **Function:** Chylomicrons transport **exogenous** (dietary) triglycerides, whereas VLDL transports **endogenous** triglycerides from the liver.

Q: The main pathway for de novo synthesis of fatty acids occurs in which cellular compartment?

Cytosol. **Explanation:** **Correct Answer: C. Cytosol** The *de novo* synthesis of fatty acids (Lipogenesis) primarily occurs in the **cytosol**. This process involves the conversion of Acetyl-CoA to Palmitate. The key enzyme complex, **Fatty Acid Synthase (FAS)**, is located in the cytoplasm. Although Acetyl-CoA is produced in the mitochondria, it cannot cross the inner mitochondrial membrane directly; it must first be converted into **Citrate** (via the Citrate-Malate Shuttle) to enter the cytosol, where it serves as the building block for fatty acid synthesis. **Analysis of Incorrect Options:** * **A. Mitochondria:** While the mitochondria are the site for **$\beta$-oxidation** (breakdown) of fatty acids and the production of Acetyl-CoA, they are not the primary site for synthesis. A minor pathway for fatty acid *elongation* occurs here, but not the main *de novo* synthesis. * **B. Nucleus:** The nucleus is responsible for genetic material storage and transcription; it does not play a direct role in lipid metabolic pathways. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-Limiting Enzyme:** Acetyl-CoA Carboxylase (ACC), which requires **Biotin** as a cofactor. * **Reductant Requirement:** **NADPH** is the essential reducing agent for fatty acid synthesis, primarily supplied by the **Hexose Monophosphate (HMP) Shunt**. * **Hormonal Regulation:** Lipogenesis is stimulated by **Insulin** (well-fed state) and inhibited by Glucagon and Epinephrine. * **End Product:** The primary end product of this cytosolic pathway is **Palmitate** (a 16-carbon saturated fatty acid).

Q: Which of the following amino acids is involved in the synthesis of ceramide?

Serine. **Explanation:** **1. Why Serine is Correct:** Ceramide is the fundamental structural unit of all sphingolipids. Its synthesis begins in the endoplasmic reticulum with the **rate-limiting step**: the condensation of **Palmitoyl-CoA** and the amino acid **L-Serine**. This reaction is catalyzed by the enzyme **Serine Palmitoyltransferase (SPT)**, which requires Pyridoxal Phosphate (Vitamin B6) as a cofactor. This condensation produces 3-ketosphinganine, which is subsequently reduced and acylated to form Ceramide. **2. Why Other Options are Incorrect:** * **Tyrosine:** Primarily involved in the synthesis of catecholamines (Dopamine, Epinephrine), Thyroid hormones, and Melanin. * **Arginine:** A precursor for Nitric Oxide (NO), Creatine, and Urea. It is not involved in sphingolipid backbone formation. * **Threonine:** An essential amino acid involved in mucin synthesis and O-linked glycosylation, but it does not contribute to the ceramide structure. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Sphingosine Backbone:** Ceramide consists of a sphingosine base attached to a fatty acid via an **amide bond**. * **Sphingomyelin:** Ceramide + Phosphocholine = Sphingomyelin (the only phospholipid that does not contain glycerol). * **Glycosphingolipids:** Ceramide + Sugars = Cerebrosides/Gangliosides. * **Clinical Correlation:** Deficiencies in enzymes that break down sphingolipids lead to **Sphingolipidoses** (e.g., Gaucher’s, Niemann-Pick, and Tay-Sachs disease). * **Key Enzyme:** Serine Palmitoyltransferase is the primary target for regulating sphingolipid levels in the cell.

Q: What is true about the conversion of 20-carbon fatty acids to prostaglandins by prostaglandin synthase?

The primary prostaglandin produced is PGH2.. **Explanation:** The synthesis of prostaglandins begins with the release of **Arachidonic acid** (a 20-carbon polyunsaturated fatty acid) from membrane phospholipids by Phospholipase A2. This arachidonic acid is then acted upon by the bifunctional enzyme **Prostaglandin Synthase** (also known as **Cyclooxygenase or COX**). **Why Option D is Correct:** Prostaglandin Synthase possesses two distinct catalytic activities: **Cyclooxygenase** (which forms PGG2) and **Peroxidase** (which reduces PGG2 to PGH2). **PGH2** is the "parent" or primary prostaglandin from which all other series-2 prostanoids (like PGE2, PGF2α, PGI2, and Thromboxanes) are derived via tissue-specific isomerases. **Analysis of Incorrect Options:** * **Option A:** PGI2 (Prostacyclin) is a downstream product synthesized from PGH2 specifically in the vascular endothelium; it is not the first one formed. * **Option B:** The rate-limiting step of the overall eicosanoid pathway is the release of arachidonic acid from the cell membrane by **Phospholipase A2**, not the COX enzyme itself. * **Option C:** Prostaglandin synthase converts Arachidonic acid to PGH2. The conversion of PGH2 to PGE2 is performed by a specific downstream enzyme, **PGE synthase**. **High-Yield Clinical Pearls for NEET-PG:** * **COX-1 vs. COX-2:** COX-1 is constitutive (gastric protection), while COX-2 is inducible (inflammation). * **Drug Targets:** Aspirin irreversibly inhibits COX-1 and COX-2 by acetylating a serine residue in the active site. * **Glucocorticoids:** These inhibit Phospholipase A2 (via Lipocortin/Annexin A1), blocking the production of all eicosanoids. * **PGI2 vs. TXA2:** PGI2 (Prostacyclin) inhibits platelet aggregation and causes vasodilation, whereas TXA2 (Thromboxane) promotes aggregation and vasoconstriction.

Q: Chemically, steroids are derivatives of which of the following?

Cholesterol. **Explanation:** The correct answer is **A. Cholesterol**. In human biochemistry, **cholesterol** is the primary precursor for the synthesis of all steroid hormones (including glucocorticoids, mineralocorticoids, and sex steroids), bile acids, and Vitamin D. While the basic chemical skeleton of all steroids is the perhydrocyclopentanophenanthrene (D) ring, the question asks what they are *derivatives* of in a biological context. Cholesterol is the parent compound from which these functional molecules are derived via enzymatic modifications in the mitochondria and endoplasmic reticulum. **Analysis of Options:** * **B. Ergosterol:** This is a sterol found in fungal cell membranes. It serves as a precursor to Vitamin D2 (ergocalciferol) but is not the precursor for human steroid hormones. * **C. Fatty acids:** These are precursors for triglycerides and phospholipids. While they provide the acetyl-CoA necessary for cholesterol synthesis, steroids are not direct derivatives of fatty acids. * **D. Perhydrocyclopentanophenanthrene:** This is the **chemical nucleus** (the 17-carbon tetracyclic skeleton) of all steroids. While chemically accurate as a structural base, in medical biochemistry, steroids are classified as derivatives of the parent molecule, cholesterol. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** The conversion of cholesterol to **pregnenolone** by the enzyme **Desmolase** (CYP11A1) is the rate-limiting step in steroidogenesis. * **Steroid Nucleus:** It consists of four fused rings (A, B, C, and D). * **Excretion:** Steroids are primarily catabolized in the liver and excreted in the urine as 17-ketosteroids. * **Key Precursor:** Remember that **Acetate** is the ultimate carbon source for the entire cholesterol (and thus steroid) molecule.

Q: Which of the following is not required for the conversion of acetyl CoA to palmitate?

Niacin. The conversion of **Acetyl CoA to Palmitate** (De novo Lipogenesis) occurs in the cytosol and involves two major stages: the formation of Malonyl CoA and the Fatty Acid Synthase (FAS) complex reactions. ### **Why Niacin is the Correct Answer** While **NADPH** is an absolute requirement for fatty acid synthesis, **Niacin (Vitamin B3)** in its free form is not a direct cofactor for the enzymes involved. The synthesis requires the *reduced coenzyme* form (NADPH), which is primarily derived from the Pentose Phosphate Pathway (HMP Shunt). In biochemistry questions of this type, a distinction is often made between the active coenzyme (NADPH) and the vitamin precursor (Niacin). While Niacin is a precursor to NADP+, it is not a direct "requirement" for the reaction steps themselves. ### **Analysis of Incorrect Options** * **Biotin (Option D):** Required by **Acetyl CoA Carboxylase**, the rate-limiting enzyme that converts Acetyl CoA to Malonyl CoA. It acts as a carrier of CO₂. * **ATP (Option A):** Required for the Acetyl CoA Carboxylase reaction to provide the energy needed to fix CO₂ onto Acetyl CoA. * **NADPH (Option C):** Required by the **Ketoacyl reductase** and **Enoyl reductase** domains of the Fatty Acid Synthase complex to reduce the growing fatty acid chain. ### **High-Yield Clinical Pearls for NEET-PG** * **Rate-limiting enzyme:** Acetyl CoA Carboxylase (inhibited by Palmitoyl CoA, activated by Citrate). * **The "Citrate Shuttle":** Acetyl CoA moves from mitochondria to cytosol in the form of Citrate. * **FAS Complex:** It is a multi-enzyme dimers; the final product released is **Palmitate (16 carbons)**. * **Key Sources of NADPH:** 1. HMP Shunt (Main), 2. Malic Enzyme, 3. Isocitrate Dehydrogenase.

Lipid Metabolism Indian Medical PG Practice Questions and MCQs

Question 1: Which organ does not utilise ketone bodies?

A. Liver (Correct Answer)
B. Brain
C. Skeletal muscles
D. Cardiac muscles

Explanation: **Explanation** The correct answer is **A. Liver**. **1. Why the Liver cannot utilize Ketone Bodies:** The liver is the primary site for **ketogenesis** (the synthesis of ketone bodies), but it cannot utilize them for energy. This is because the liver lacks the essential enzyme **Thiophorase** (also known as Succinyl-CoA:3-ketoacid CoA transferase). In extrahepatic tissues, Thiophorase converts Acetoacetate into Acetoacetyl-CoA by transferring a CoA group from Succinyl-CoA. Without this enzyme, the liver cannot activate ketone bodies to enter the TCA cycle, preventing a "futile cycle" where the liver would consume the fuel it is supposed to export to the rest of the body. **2. Why the other options are incorrect:** * **B. Brain:** During prolonged fasting or starvation, the brain adapts to use ketone bodies (specifically 3-hydroxybutyrate and acetoacetate) as its primary energy source, reducing its dependence on glucose. * **C & D. Skeletal and Cardiac Muscles:** These tissues possess high levels of Thiophorase. In the early stages of fasting, muscles are the primary consumers of ketone bodies to spare glucose for the brain. **High-Yield NEET-PG Pearls:** * **Rate-limiting enzyme of Ketogenesis:** HMG-CoA Synthase (Mitochondrial). * **Ketone bodies include:** Acetone (non-metabolizable, excreted in breath), Acetoacetate, and β-Hydroxybutyrate. * **Site of Ketogenesis:** Mitochondria of hepatocytes. * **Key Enzyme for Utilization:** Thiophorase (absent in Liver). * **Clinical Sign:** "Fruity odor" of breath in Diabetic Ketoacidosis (DKA) is due to the excretion of Acetone.

Question 2: Reverse cholesterol transport is mediated by which lipoprotein?

A. HDL (Correct Answer)
B. VLDL
C. LDL
D. IDL

Explanation: **Explanation:** **Reverse Cholesterol Transport (RCT)** is the physiological process by which excess cholesterol is removed from peripheral tissues (like macrophages in the arterial wall) and transported back to the liver for excretion in bile. **HDL (High-Density Lipoprotein)** is the primary mediator of this process, which is why it is clinically referred to as "Good Cholesterol." The process involves: 1. **Efflux:** Free cholesterol is moved from cells to nascent HDL via **ABCA1 transporters**. 2. **Esterification:** The enzyme **LCAT** (Lecithin-Cholesterol Acyltransferase) converts free cholesterol into cholesterol esters, trapping them in the HDL core. 3. **Hepatic Uptake:** HDL delivers these esters to the liver via **SR-BI receptors** or transfers them to other lipoproteins via **CETP**. **Why other options are incorrect:** * **VLDL (Very Low-Density Lipoprotein):** Synthesized in the liver to transport endogenous triglycerides to peripheral tissues. * **LDL (Low-Density Lipoprotein):** Known as "Bad Cholesterol," it transports cholesterol **from** the liver **to** peripheral tissues. High levels are associated with atherosclerosis. * **IDL (Intermediate-Density Lipoprotein):** A transient product formed during the conversion of VLDL to LDL; it is not involved in RCT. **High-Yield NEET-PG Pearls:** * **Apo A-I:** The major apoprotein associated with HDL and a potent activator of LCAT. * **Tangier Disease:** A genetic deficiency of ABCA1 transporters resulting in extremely low HDL levels and orange-colored tonsils. * **Anti-atherogenic property:** HDL prevents foam cell formation, reducing the risk of Coronary Artery Disease (CAD).

Question 3: Lipid is required in the average diet because it:

A. has a high caloric value
B. provides essential fatty acids (Correct Answer)
C. aids in absorption of carbohydrates
D. is necessary for storage of carbohydrates

Explanation: **Explanation:** The primary nutritional requirement for lipids in the diet is to provide **Essential Fatty Acids (EFAs)**—specifically **Linoleic acid (omega-6)** and **Alpha-linolenic acid (omega-3)**. These are termed "essential" because the human body lacks the enzymes (**desaturases** beyond carbon 9) required to synthesize them de novo. These fatty acids are vital precursors for the synthesis of eicosanoids (prostaglandins, leukotrienes) and are structural components of cell membranes. **Analysis of Options:** * **Option A (High caloric value):** While lipids are the most energy-dense macronutrient (9 kcal/g), this is a characteristic, not the primary biological *requirement*. The body can derive sufficient calories from carbohydrates and proteins if necessary. * **Option C & D (Carbohydrate metabolism):** Lipids do not aid in the absorption of carbohydrates, nor are they necessary for their storage. Carbohydrates are stored as glycogen in the liver and muscles. **High-Yield NEET-PG Pearls:** 1. **EFA Deficiency:** Clinically presents as **Phrynoderma** (follicular hyperkeratosis/toad skin), poor wound healing, and alopecia. 2. **Fat-Soluble Vitamins:** Dietary lipids are also essential for the absorption of Vitamins **A, D, E, and K**. 3. **Arachidonic Acid:** It is considered "semi-essential" because it can be synthesized from Linoleic acid. 4. **Energy Storage:** Lipids are stored in the body as **Triacylglycerols (TAGs)** in adipose tissue, which serves as the body's main energy reservoir.

Question 4: What is the concentration of the reagent used for determining the Reichert-Meissl number?

A. 0.1 N KOH (Correct Answer)
B. 0.5 N KOH
C. 0.1 N NaOH
D. 0.5 N NaOH

Explanation: **Explanation:** The **Reichert-Meissl (RM) number** is a critical analytical constant used in lipid biochemistry to determine the amount of volatile, water-soluble fatty acids (primarily butyric and caproic acid) present in a fat or oil. **Why 0.1 N KOH is correct:** The RM number is defined as the number of milliliters of **0.1 N Potassium Hydroxide (KOH)** required to neutralize the steam-volatile, water-soluble fatty acids distilled from 5 grams of fat. KOH is the standard alkali used in this titration process because it effectively neutralizes the short-chain fatty acids (like butyric acid) that are characteristic of milk fats. **Analysis of Incorrect Options:** * **0.5 N KOH (B):** This concentration is too high. 0.5 N KOH is typically used in the determination of the **Saponification Number**, where a stronger alkali is needed to hydrolyze all fatty acids in a sample. * **0.1 N and 0.5 N NaOH (C & D):** While Sodium Hydroxide (NaOH) is a strong base, the standard protocol for RM number specifically mandates KOH. In lipid chemistry, KOH is preferred for many titrations because it is more soluble in organic solvents (like ethanol) often used during the preparation of fat samples. **High-Yield Clinical Pearls for NEET-PG:** * **Significance:** The RM number is primarily used to detect the **adulteration of Ghee or Butter**. * **Normal Value:** Pure Ghee/Butter has a high RM number (typically **24–30**) due to its high content of butyric acid. * **Adulteration:** If butter is adulterated with animal fats or vegetable oils (which have very low RM numbers, usually <1), the RM value of the sample will significantly decrease. * **Related Constant:** The **Polenske Number** also uses 0.1 N KOH but measures steam-volatile, water-**insoluble** fatty acids (like caprylic and capric acid).

Question 5: Which lipoprotein has the highest quantity of lipid and the lowest concentration of protein?

A. Chylomicrons (Correct Answer)
B. Very low density lipoproteins
C. Low density lipoproteins
D. High density lipoproteins

Explanation: ### Explanation Lipoproteins are classified based on their **density**, which is determined by the ratio of lipids to proteins. Since lipids have a lower density than water and proteins have a higher density, the lipoprotein with the most lipid and least protein will be the least dense. **1. Why Chylomicrons are correct:** Chylomicrons are the largest and least dense of all lipoproteins. They consist of approximately **98-99% lipid** (predominantly exogenous triglycerides) and only **1-2% protein**. Because they have the highest lipid-to-protein ratio, they float to the top when plasma is left standing, forming a creamy supernate. **2. Analysis of Incorrect Options:** * **VLDL (Very Low Density Lipoproteins):** These are the second least dense. They contain about 90% lipid (mainly endogenous triglycerides) and 10% protein. * **LDL (Low Density Lipoproteins):** Known as "bad cholesterol," they contain about 75-80% lipid (primarily cholesterol) and 20-25% protein. * **HDL (High Density Lipoproteins):** Known as "good cholesterol," these are the smallest and densest. They have the **highest concentration of protein** (approx. 40-55%) and the lowest quantity of lipid. **3. High-Yield NEET-PG Pearls:** * **Electrophoretic Mobility:** On electrophoresis (pH 8.6), the order of mobility from origin to anode is: **Chylomicrons (Origin) < LDL (Beta) < VLDL (Pre-beta) < HDL (Alpha).** Note that VLDL moves faster than LDL despite being less dense. * **Apolipoprotein Markers:** * Chylomicrons: **Apo B-48** (unique marker). * VLDL/IDL/LDL: **Apo B-100**. * HDL: **Apo A-I** (activates LCAT). * **Function:** Chylomicrons transport **exogenous** (dietary) triglycerides, whereas VLDL transports **endogenous** triglycerides from the liver.

Question 6: The main pathway for de novo synthesis of fatty acids occurs in which cellular compartment?

A. Mitochondria
B. Nucleus
C. Cytosol (Correct Answer)
D. None of the above

Explanation: **Explanation:** **Correct Answer: C. Cytosol** The *de novo* synthesis of fatty acids (Lipogenesis) primarily occurs in the **cytosol**. This process involves the conversion of Acetyl-CoA to Palmitate. The key enzyme complex, **Fatty Acid Synthase (FAS)**, is located in the cytoplasm. Although Acetyl-CoA is produced in the mitochondria, it cannot cross the inner mitochondrial membrane directly; it must first be converted into **Citrate** (via the Citrate-Malate Shuttle) to enter the cytosol, where it serves as the building block for fatty acid synthesis. **Analysis of Incorrect Options:** * **A. Mitochondria:** While the mitochondria are the site for **$\beta$-oxidation** (breakdown) of fatty acids and the production of Acetyl-CoA, they are not the primary site for synthesis. A minor pathway for fatty acid *elongation* occurs here, but not the main *de novo* synthesis. * **B. Nucleus:** The nucleus is responsible for genetic material storage and transcription; it does not play a direct role in lipid metabolic pathways. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-Limiting Enzyme:** Acetyl-CoA Carboxylase (ACC), which requires **Biotin** as a cofactor. * **Reductant Requirement:** **NADPH** is the essential reducing agent for fatty acid synthesis, primarily supplied by the **Hexose Monophosphate (HMP) Shunt**. * **Hormonal Regulation:** Lipogenesis is stimulated by **Insulin** (well-fed state) and inhibited by Glucagon and Epinephrine. * **End Product:** The primary end product of this cytosolic pathway is **Palmitate** (a 16-carbon saturated fatty acid).

Question 7: Which of the following amino acids is involved in the synthesis of ceramide?

A. Serine (Correct Answer)
B. Tyrosine
C. Arginine
D. Threonine

Explanation: **Explanation:** **1. Why Serine is Correct:** Ceramide is the fundamental structural unit of all sphingolipids. Its synthesis begins in the endoplasmic reticulum with the **rate-limiting step**: the condensation of **Palmitoyl-CoA** and the amino acid **L-Serine**. This reaction is catalyzed by the enzyme **Serine Palmitoyltransferase (SPT)**, which requires Pyridoxal Phosphate (Vitamin B6) as a cofactor. This condensation produces 3-ketosphinganine, which is subsequently reduced and acylated to form Ceramide. **2. Why Other Options are Incorrect:** * **Tyrosine:** Primarily involved in the synthesis of catecholamines (Dopamine, Epinephrine), Thyroid hormones, and Melanin. * **Arginine:** A precursor for Nitric Oxide (NO), Creatine, and Urea. It is not involved in sphingolipid backbone formation. * **Threonine:** An essential amino acid involved in mucin synthesis and O-linked glycosylation, but it does not contribute to the ceramide structure. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Sphingosine Backbone:** Ceramide consists of a sphingosine base attached to a fatty acid via an **amide bond**. * **Sphingomyelin:** Ceramide + Phosphocholine = Sphingomyelin (the only phospholipid that does not contain glycerol). * **Glycosphingolipids:** Ceramide + Sugars = Cerebrosides/Gangliosides. * **Clinical Correlation:** Deficiencies in enzymes that break down sphingolipids lead to **Sphingolipidoses** (e.g., Gaucher’s, Niemann-Pick, and Tay-Sachs disease). * **Key Enzyme:** Serine Palmitoyltransferase is the primary target for regulating sphingolipid levels in the cell.

Question 8: What is true about the conversion of 20-carbon fatty acids to prostaglandins by prostaglandin synthase?

A. The first prostaglandin synthesized is PGI2.
B. Prostaglandin synthase is the rate-limiting enzyme.
C. It converts PGH2 to PGE2.
D. The primary prostaglandin produced is PGH2. (Correct Answer)

Explanation: **Explanation:** The synthesis of prostaglandins begins with the release of **Arachidonic acid** (a 20-carbon polyunsaturated fatty acid) from membrane phospholipids by Phospholipase A2. This arachidonic acid is then acted upon by the bifunctional enzyme **Prostaglandin Synthase** (also known as **Cyclooxygenase or COX**). **Why Option D is Correct:** Prostaglandin Synthase possesses two distinct catalytic activities: **Cyclooxygenase** (which forms PGG2) and **Peroxidase** (which reduces PGG2 to PGH2). **PGH2** is the "parent" or primary prostaglandin from which all other series-2 prostanoids (like PGE2, PGF2α, PGI2, and Thromboxanes) are derived via tissue-specific isomerases. **Analysis of Incorrect Options:** * **Option A:** PGI2 (Prostacyclin) is a downstream product synthesized from PGH2 specifically in the vascular endothelium; it is not the first one formed. * **Option B:** The rate-limiting step of the overall eicosanoid pathway is the release of arachidonic acid from the cell membrane by **Phospholipase A2**, not the COX enzyme itself. * **Option C:** Prostaglandin synthase converts Arachidonic acid to PGH2. The conversion of PGH2 to PGE2 is performed by a specific downstream enzyme, **PGE synthase**. **High-Yield Clinical Pearls for NEET-PG:** * **COX-1 vs. COX-2:** COX-1 is constitutive (gastric protection), while COX-2 is inducible (inflammation). * **Drug Targets:** Aspirin irreversibly inhibits COX-1 and COX-2 by acetylating a serine residue in the active site. * **Glucocorticoids:** These inhibit Phospholipase A2 (via Lipocortin/Annexin A1), blocking the production of all eicosanoids. * **PGI2 vs. TXA2:** PGI2 (Prostacyclin) inhibits platelet aggregation and causes vasodilation, whereas TXA2 (Thromboxane) promotes aggregation and vasoconstriction.

Question 9: Chemically, steroids are derivatives of which of the following?

A. Cholesterol (Correct Answer)
B. Ergosterol
C. Fatty acids
D. Perhydrocyclopentanophenanthrene

Explanation: **Explanation:** The correct answer is **A. Cholesterol**. In human biochemistry, **cholesterol** is the primary precursor for the synthesis of all steroid hormones (including glucocorticoids, mineralocorticoids, and sex steroids), bile acids, and Vitamin D. While the basic chemical skeleton of all steroids is the perhydrocyclopentanophenanthrene (D) ring, the question asks what they are *derivatives* of in a biological context. Cholesterol is the parent compound from which these functional molecules are derived via enzymatic modifications in the mitochondria and endoplasmic reticulum. **Analysis of Options:** * **B. Ergosterol:** This is a sterol found in fungal cell membranes. It serves as a precursor to Vitamin D2 (ergocalciferol) but is not the precursor for human steroid hormones. * **C. Fatty acids:** These are precursors for triglycerides and phospholipids. While they provide the acetyl-CoA necessary for cholesterol synthesis, steroids are not direct derivatives of fatty acids. * **D. Perhydrocyclopentanophenanthrene:** This is the **chemical nucleus** (the 17-carbon tetracyclic skeleton) of all steroids. While chemically accurate as a structural base, in medical biochemistry, steroids are classified as derivatives of the parent molecule, cholesterol. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** The conversion of cholesterol to **pregnenolone** by the enzyme **Desmolase** (CYP11A1) is the rate-limiting step in steroidogenesis. * **Steroid Nucleus:** It consists of four fused rings (A, B, C, and D). * **Excretion:** Steroids are primarily catabolized in the liver and excreted in the urine as 17-ketosteroids. * **Key Precursor:** Remember that **Acetate** is the ultimate carbon source for the entire cholesterol (and thus steroid) molecule.

Question 10: Which of the following is not required for the conversion of acetyl CoA to palmitate?

A. ATP
B. Niacin (Correct Answer)
C. NADPH
D. Biotin

Explanation: The conversion of **Acetyl CoA to Palmitate** (De novo Lipogenesis) occurs in the cytosol and involves two major stages: the formation of Malonyl CoA and the Fatty Acid Synthase (FAS) complex reactions. ### **Why Niacin is the Correct Answer** While **NADPH** is an absolute requirement for fatty acid synthesis, **Niacin (Vitamin B3)** in its free form is not a direct cofactor for the enzymes involved. The synthesis requires the *reduced coenzyme* form (NADPH), which is primarily derived from the Pentose Phosphate Pathway (HMP Shunt). In biochemistry questions of this type, a distinction is often made between the active coenzyme (NADPH) and the vitamin precursor (Niacin). While Niacin is a precursor to NADP+, it is not a direct "requirement" for the reaction steps themselves. ### **Analysis of Incorrect Options** * **Biotin (Option D):** Required by **Acetyl CoA Carboxylase**, the rate-limiting enzyme that converts Acetyl CoA to Malonyl CoA. It acts as a carrier of CO₂. * **ATP (Option A):** Required for the Acetyl CoA Carboxylase reaction to provide the energy needed to fix CO₂ onto Acetyl CoA. * **NADPH (Option C):** Required by the **Ketoacyl reductase** and **Enoyl reductase** domains of the Fatty Acid Synthase complex to reduce the growing fatty acid chain. ### **High-Yield Clinical Pearls for NEET-PG** * **Rate-limiting enzyme:** Acetyl CoA Carboxylase (inhibited by Palmitoyl CoA, activated by Citrate). * **The "Citrate Shuttle":** Acetyl CoA moves from mitochondria to cytosol in the form of Citrate. * **FAS Complex:** It is a multi-enzyme dimers; the final product released is **Palmitate (16 carbons)**. * **Key Sources of NADPH:** 1. HMP Shunt (Main), 2. Malic Enzyme, 3. Isocitrate Dehydrogenase.

Practice by Chapter

Lipid Classification and Chemistry

Practice Questions

Fatty Acid Oxidation

Practice Questions

Ketone Body Metabolism

Practice Questions

Fatty Acid Synthesis

Practice Questions

Metabolism of Triacylglycerols

Practice Questions

Phospholipid Metabolism

Practice Questions

Cholesterol Metabolism and Biosynthesis

Practice Questions

Bile Acids and Bile Salts

Practice Questions

Lipoprotein Metabolism and Transport

Practice Questions

Dyslipidemias and Atherosclerosis

Practice Questions

Prostaglandins and Eicosanoids

Practice Questions

Fatty Liver and Lipotropic Factors

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free